Call Now

Mon-Fri, 8 AM-8 PM ET

If you want to get involved with the CVT-301 Trial

or

Give us your contact information and we'll get back to you.

CALL ME BACK
Home > English > Home

A Phase 3 Clinical Trial for People with Parkinson's Disease Experiencing OFF Episodes

The goal of the CVT-301 Trial is to determine the effectiveness and safety of an inhaled powder form of levodopa in people with Parkinson's disease experiencing OFF episodes (motor response fluctuations).

You may be eligible to participate if you:

  • Have Idiopathic Parkinson's disease and be between the ages of 30 and 80 years old
  • Take levodopa-containing medication
  • Experience OFF episodes
  • Are not pregnant or breastfeeding
View All Eligibility Requirements